JP2005179557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005179557A5 JP2005179557A5 JP2003424376A JP2003424376A JP2005179557A5 JP 2005179557 A5 JP2005179557 A5 JP 2005179557A5 JP 2003424376 A JP2003424376 A JP 2003424376A JP 2003424376 A JP2003424376 A JP 2003424376A JP 2005179557 A5 JP2005179557 A5 JP 2005179557A5
- Authority
- JP
- Japan
- Prior art keywords
- phenylene
- group
- difluoro
- ocf
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
式中、Raは基(3−1)、基(3−2)、基(3−3)、基(3−4)、基(3−5)または基(3−6)であり、ここにRdは独立に水素、ハロゲンまたは炭素数1〜5のアルキルであり、これらのアルキルにおいて任意の水素はハロゲンで置き換えられてもよいが、基(3−6)においては3個のRdが同時に水素であることはなく;Rbは水素、ハロゲン、−CF3、−CF2H、−CFH2、−OCF3、−OCF2H、−N=C=O、−N=C=S、または炭素数1〜20のアルキルであり、これらのアルキルにおいて任意の−CH2−は−O−、−S−、−CO−、−COO−、−OCO−、−CH=CH−、−CF=CF−、または−C≡C−で置き換えられてもよく、これらのアルキルにおいて任意の水素はハロゲンで置き換えられてもよく;Rcは基(3−1)、基(3−2)、基(3−3)、基(3−4)、基(3−5)、または基(3−6)であり、ここにRdは独立に水素、ハロゲンまたは炭素数1〜5のアルキルであり、これらのアルキルにおいて任意の水素はハロゲンで置き換えられてもよく;Aは独立に1,4−シクロヘキシレン、1,4−シクロヘキセニレン、1,4−フェニレン、テトラヒドロナフタレン−2,6−ジイル、またはビシクロ[2.2.2]オクタン−1,4−ジイルであり、これらの環において任意の−CH2−は−O−で置き換えられてもよく、任意の−CH=は−N=で置き換えられてもよく、これらの環において任意の水素はハロゲン、炭素数1〜5のアルキルまたは炭素数1〜5のハロゲン化アルキルで置き換えられてもよく;Yは炭素数1〜20のアルキレンであり、これらのアルキレンにおいて任意の−CH2−は−O−、−S−、−COO−、または−OCO−で置き換えられてもよく;Zは独立に単結合、−(CH2)n−、−O(CH2)n−、−(CH2)nO−、−O(CH2)nO−、−CH=CH−、−C≡C−、−COO−、−OCO−、−(CF2)2−、−C≡C−COO−、−OCO−C≡C−、−CH=CH−(CH2)2−、−(CH2)2−CH=CH−、−CF=CF−、−C≡C−CH=CH−、−CH=CH−C≡C−、−OCF2−、または−CF2O−であり、ここにnは1〜20の整数であり;mは1〜6の整数である。ただし、mが1または2、Rcがアクリロイルオキシ、Yに隣接するA−ZにおいてAが1,4−フェニレン、かつ、Zが−OCO−のときRbはアルキルではなく、アルコキシでもなく、mが2でR c がメタクリロイルオキシ、Yが−C 3 H 6 −、Yに隣接する2つのA−ZにおいてAが1,4−シクロヘキシレン、Zが単結合、R b に隣接するAが1,4−フェニレンのときR b はメチルではなく、そしてmが2でR c が(3−4)、Yが−C 2 H 4 −、Yに隣接する2つのA−ZにおいてAが1,4−シクロヘキシレン、Zが単結合、R b に隣接するAが1,4−フェニレンでR b のオルト位の水素がフッ素で置き換えられるときR b はフッ素ではない。
以 上
In the formula, R a is a group (3-1), a group (3-2), a group (3-3), a group (3-4), a group (3-5) or a group (3-6); Here, R d is independently hydrogen, halogen, or alkyl having 1 to 5 carbon atoms. In these alkyls, any hydrogen may be replaced by halogen, but in the group (3-6), 3 R d is not simultaneously hydrogen; R b is hydrogen, halogen, —CF 3 , —CF 2 H, —CFH 2 , —OCF 3 , —OCF 2 H, —N═C═O, —N═C ═S, or alkyl having 1 to 20 carbon atoms, and in these alkyl, any —CH 2 — is —O—, —S—, —CO—, —COO—, —OCO—, —CH═CH—. , -CF = CF-, or -C≡C-, and in these alkyls any hydrogen is It may be replaced by Gen; R c is a group (3-1), group (3-2), group (3-3), group (3-4), group (3-5), or a group (3 -6), wherein R d is independently hydrogen, halogen, or alkyl of 1 to 5 carbons, in which any hydrogen may be replaced by halogen; A is independently 1,4 -Cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydronaphthalene-2,6-diyl, or bicyclo [2.2.2] octane-1,4-diyl, in these rings Arbitrary —CH 2 — may be replaced by —O—, Arbitrary —CH═ may be replaced by —N═, and in these rings, any hydrogen is halogen, alkyl having 1 to 5 carbon atoms. Or an alkyl halide having 1 to 5 carbon atoms May be replaced; Y is alkylene having 1 to 20 carbon atoms, any -CH 2 - in these alkylene - is -O -, - S -, - COO-, or -OCO- be replaced by Well; Z is independently a single bond, — (CH 2 ) n —, —O (CH 2 ) n —, — (CH 2 ) n O—, —O (CH 2 ) n O—, —CH═CH— , —C≡C—, —COO—, —OCO—, — (CF 2 ) 2 —, —C≡C—COO—, —OCO—C≡C—, —CH═CH— (CH 2 ) 2 — , — (CH 2 ) 2 —CH═CH—, —CF═CF—, —C≡C—CH═CH—, —CH═CH—C≡C—, —OCF 2 —, or —CF 2 O— Where n is an integer from 1 to 20; m is an integer from 1 to 6. However, m is 1 or 2, R c is acryloyloxy, A in A-Z adjacent to Y is 1,4-phenylene and,, R b when Z is -OCO- are not alkyl, rather at alkoxy , M is 2, R c is methacryloyloxy, Y is —C 3 H 6 —, and in two AZs adjacent to Y, A is 1,4-cyclohexylene, Z is a single bond, and A is adjacent to R b When R is 1,4-phenylene, R b is not methyl, and m is 2, R c is (3-4), Y is —C 2 H 4 —, and A in two AZ adjacent to Y is A 1,4-cyclohexylene, Z is a single bond, R b when a adjacent R b is hydrogen ortho R b 1,4-phenylene is replaced by fluorine have name with fluorine.
that's all
Claims (29)
Ra−(A−Z)m−A−Rb (1)
Rc−Y−(A−Z)m−A−Rb (2)
式中、Raは基(3−1)、基(3−2)、基(3−3)、基(3−4)、基(3−5)または基(3−6)であり、ここにRdは独立に水素、ハロゲンまたは炭素数1〜5のアルキルであり、これらのアルキルにおいて任意の水素はハロゲンで置き換えられてもよいが、基(3−6)においては3個のRdが同時に水素であることはなく;Rbは水素、ハロゲン、−CF3、−CF2H、−CFH2、−OCF3、−OCF2H、−N=C=O、−N=C=S、または炭素数1〜20のアルキルであり、これらのアルキルにおいて任意の−CH2−は−O−、−S−、−CO−、−COO−、−OCO−、−CH=CH−、−CF=CF−、または−C≡C−で置き換えられてもよく、これらのアルキルにおいて任意の水素はハロゲンで置き換えられてもよく;Rcは基(3−1)、基(3−2)、基(3−3)、基(3−4)、基(3−5)、または基(3−6)であり、ここにRdは独立に水素、ハロゲンまたは炭素数1〜5のアルキルであり、これらのアルキルにおいて任意の水素はハロゲンで置き換えられてもよく;Aは独立に1,4−シクロヘキシレン、1,4−シクロヘキセニレン、1,4−フェニレン、テトラヒドロナフタレン−2,6−ジイル、またはビシクロ[2.2.2]オクタン−1,4−ジイルであり、これらの環において任意の−CH2−は−O−で置き換えられてもよく、任意の−CH=は−N=で置き換えられてもよく、これらの環において任意の水素はハロゲン、炭素数1〜5のアルキルまたは炭素数1〜5のハロゲン化アルキルで置き換えられてもよく;Yは炭素数1〜20のアルキレンであり、これらのアルキレンにおいて任意の−CH2−は−O−、−S−、−COO−、または−OCO−で置き換えられてもよく;Zは独立に単結合、−(CH2)n−、−O(CH2)n−、−(CH2)nO−、−O(CH2)nO−、−CH=CH−、−C≡C−、−COO−、−OCO−、−(CF2)2−、−C≡C−COO−、−OCO−C≡C−、−CH=CH−(CH2)2−、−(CH2)2−CH=CH−、−CF=CF−、−C≡C−CH=CH−、−CH=CH−C≡C−、−OCF2−、または−CF2O−であり、ここにnは1〜20の整数であり;mは1〜6の整数である。ただし、mが1または2、Rcがアクリロイルオキシ、Yに隣接するA−ZにおいてAが1,4−フェニレン、かつ、Zが−OCO−のときRbはアルキルではなく、アルコキシでもなく、mが2でR c がメタクリロイルオキシ、Yが−C 3 H 6 −、Yに隣接する2つのA−ZにおいてAが1,4−シクロヘキシレン、Zが単結合、R b に隣接するAが1,4−フェニレンのときR b はメチルではなく、そしてmが2でR c が(3−4)、Yが−C 2 H 4 −、Yに隣接する2つのA−ZにおいてAが1,4−シクロヘキシレン、Zが単結合、R b に隣接するAが1,4−フェニレンでR b のオルト位の水素がフッ素で置き換えられるときR b はフッ素ではない。 A compound represented by the following formula (1) or formula (2).
R a- (A−Z) m−A−R b (1)
R c -Y- (A-Z) m-A-R b (2)
In the formula, R a is a group (3-1), a group (3-2), a group (3-3), a group (3-4), a group (3-5) or a group (3-6); Here, R d is independently hydrogen, halogen, or alkyl having 1 to 5 carbon atoms. In these alkyls, any hydrogen may be replaced by halogen, but in the group (3-6), 3 R d is not simultaneously hydrogen; R b is hydrogen, halogen, —CF 3 , —CF 2 H, —CFH 2 , —OCF 3 , —OCF 2 H, —N═C═O, —N═C ═S, or alkyl having 1 to 20 carbon atoms, and in these alkyl, any —CH 2 — is —O—, —S—, —CO—, —COO—, —OCO—, —CH═CH—. , -CF = CF-, or -C≡C-, and in these alkyls any hydrogen is It may be replaced by Gen; R c is a group (3-1), group (3-2), group (3-3), group (3-4), group (3-5), or a group (3 -6), wherein R d is independently hydrogen, halogen, or alkyl of 1 to 5 carbons, in which any hydrogen may be replaced by halogen; A is independently 1,4 -Cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydronaphthalene-2,6-diyl, or bicyclo [2.2.2] octane-1,4-diyl, in these rings Arbitrary —CH 2 — may be replaced by —O—, Arbitrary —CH═ may be replaced by —N═, and in these rings, any hydrogen is halogen, alkyl having 1 to 5 carbon atoms. Or an alkyl halide having 1 to 5 carbon atoms May be replaced; Y is alkylene having 1 to 20 carbon atoms, any -CH 2 - in these alkylene - is -O -, - S -, - COO-, or -OCO- be replaced by Well; Z is independently a single bond, — (CH 2 ) n —, —O (CH 2 ) n —, — (CH 2 ) n O—, —O (CH 2 ) n O—, —CH═CH— , —C≡C—, —COO—, —OCO—, — (CF 2 ) 2 —, —C≡C—COO—, —OCO—C≡C—, —CH═CH— (CH 2 ) 2 — , — (CH 2 ) 2 —CH═CH—, —CF═CF—, —C≡C—CH═CH—, —CH═CH—C≡C—, —OCF 2 —, or —CF 2 O— Where n is an integer from 1 to 20; m is an integer from 1 to 6. However, m is 1 or 2, R c is acryloyloxy, A in A-Z adjacent to Y is 1,4-phenylene and,, R b when Z is -OCO- are not alkyl, rather at alkoxy , M is 2, R c is methacryloyloxy, Y is —C 3 H 6 —, and in two AZs adjacent to Y, A is 1,4-cyclohexylene, Z is a single bond, and A is adjacent to R b When R is 1,4-phenylene, R b is not methyl, and m is 2, R c is (3-4), Y is —C 2 H 4 —, and A in two AZ adjacent to Y is A 1,4-cyclohexylene, Z is a single bond, R b when a adjacent R b is hydrogen ortho R b 1,4-phenylene is replaced by fluorine have name with fluorine.
Ra−A−Z−A−Rb (I)
Ra−(A−Z)2−A−Rb (II)
Ra−(A−Z)3−A−Rb (III)
Ra−(A−Z)4−A−Rb (IV)
Rc−Y−A−Z−A−Rb (V)
Rc−Y−(A−Z)2−A−Rb (VI)
Rc−Y−(A−Z)3−A−Rb (VII)
Rc−Y−(A−Z)4−A−Rb (VIII)
式中、RaおよびRcは基(3−1)、基(3−2)、基(3−3)、基(3−4)、基(3−5)または基(3−6)であり;Rbが水素、ハロゲン、−CF3、−CF2H、−CFH2、−OCF3、−OCF2H、炭素数1〜5のアルキル、または炭素数1〜5のアルコキシであり;Rdは水素、ハロゲンまたはメチルであり;Aが1,4−シクロヘキシレン、1,4−シクロヘキセニレン、1,3−ジオキサン−2,5−ジイル、1,4−フェニレン、2−フルオロ−1,4−フェニレン、2,3−ジフルオロ−1,4−フェニレン、2,5−ジフルオロ−1,4−フェニレン、2,6−ジフルオロ−1,4−フェニレン、テトラヒドロナフタレン−2,6−ジイル、ピリジン−2,5−ジイル、またはピリミジン−2,5−ジイルであり;Yが炭素数1〜20のアルキレン、−O(CH2)r−、または−(CH2)rO−であり、rは1〜19の整数であり;Zが単結合、−(CH2)n−、−O(CH2)n−、−(CH2)nO−、−CH=CH−、−C≡C−、−COO−、−OCO−、−OCF2−、または−CF2O−であり、nは1〜20の整数である。 The compound according to claim 1, wherein the compound represented by the formula (1) or the formula (2) is any one compound represented by the following formulas (I) to (VIII).
R a -AZ-A-R b (I)
R a- (A-Z) 2 -A-R b (II)
R a- (AZ) 3 -A-R b (III)
R a- (AZ) 4 -A-R b (IV)
R c -Y-A-Z- A-R b (V)
R c -Y- (A-Z) 2 -A-R b (VI)
R c -Y- (A-Z) 3 -A-R b (VII)
R c -Y- (A-Z) 4 -A-R b (VIII)
In the formula, R a and R c are a group (3-1), a group (3-2), a group (3-3), a group (3-4), a group (3-5) or a group (3-6). R b is hydrogen, halogen, —CF 3 , —CF 2 H, —CFH 2 , —OCF 3 , —OCF 2 H, alkyl having 1 to 5 carbons, or alkoxy having 1 to 5 carbons Rd is hydrogen, halogen or methyl; A is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro; -1,4-phenylene, 2,3-difluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, tetrahydronaphthalene-2,6- Diyl, pyridine-2,5-diyl, or pyrimidine-2, - be diyl; Y is alkylene having 1 to 20 carbon atoms, -O (CH 2) r - , or - (CH 2) r is O-, r is an 1-19 integer; Z is a single bond , — (CH 2 ) n —, —O (CH 2 ) n —, — (CH 2 ) n O—, —CH═CH—, —C≡C—, —COO—, —OCO—, —OCF 2 -, or -CF 2 is a O-, n is an integer from 1 to 20.
The polymer obtained from the compound of Claims 1-18 which has at least 1 sort (s) of the structural unit shown by Formula (6-1)-(6-6).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003424376A JP4923380B2 (en) | 2003-12-22 | 2003-12-22 | Low refractive index anisotropic compounds, compositions and polymers or polymer compositions thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003424376A JP4923380B2 (en) | 2003-12-22 | 2003-12-22 | Low refractive index anisotropic compounds, compositions and polymers or polymer compositions thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005179557A JP2005179557A (en) | 2005-07-07 |
JP2005179557A5 true JP2005179557A5 (en) | 2006-11-30 |
JP4923380B2 JP4923380B2 (en) | 2012-04-25 |
Family
ID=34784591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003424376A Expired - Fee Related JP4923380B2 (en) | 2003-12-22 | 2003-12-22 | Low refractive index anisotropic compounds, compositions and polymers or polymer compositions thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4923380B2 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070119007A (en) * | 2005-04-13 | 2007-12-18 | 아사히 가라스 가부시키가이샤 | Polymerizable liquid crystal composition, optical anisotropic material, optical element, and optical head device |
US7919648B2 (en) | 2005-12-08 | 2011-04-05 | Chisso Corporation | Lateral α-substituted acrylate compound and polymer thereof |
JP5163019B2 (en) * | 2006-09-06 | 2013-03-13 | Jnc株式会社 | Cyclohexene derivative having alkenyl, liquid crystal composition, and liquid crystal display device |
JP5803076B2 (en) * | 2009-10-13 | 2015-11-04 | Jnc株式会社 | Polymerizable liquid crystal compound and polymer thereof |
JP5962949B2 (en) * | 2011-11-28 | 2016-08-03 | Dic株式会社 | Polymerizable liquid crystal compound |
JP6031781B2 (en) * | 2012-03-01 | 2016-11-24 | Dic株式会社 | Polymerizable compound and liquid crystal composition using the same |
JP5962347B2 (en) * | 2012-05-08 | 2016-08-03 | Jsr株式会社 | Novel (meth) acrylic acid ester and polymer thereof |
EP2970121B1 (en) * | 2013-03-15 | 2017-12-13 | Araxes Pharma LLC | Covalent inhibitors of kras g12c |
US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
TWI659021B (en) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Inhibitors of kras g12c |
JO3556B1 (en) | 2014-09-18 | 2020-07-05 | Araxes Pharma Llc | Combination therapies for treatment of cancer |
CN104610978B (en) * | 2015-02-09 | 2017-01-25 | 石家庄诚志永华显示材料有限公司 | Liquid crystal compounds and liquid crystal medium containing same |
EP3260450A4 (en) * | 2015-02-17 | 2018-10-10 | JNC Corporation | Compound having saturated six-membered ring and alkoxy group or alkoxyalkyl group, liquid crystal composition and liquid crystal display element |
TW201702232A (en) | 2015-04-10 | 2017-01-16 | 亞瑞克西斯製藥公司 | Substituted quinazoline compounds and methods of use thereof |
US10428064B2 (en) | 2015-04-15 | 2019-10-01 | Araxes Pharma Llc | Fused-tricyclic inhibitors of KRAS and methods of use thereof |
WO2016208483A1 (en) * | 2015-06-25 | 2016-12-29 | Dic株式会社 | Polymerizable compound and liquid crystal display element using same |
JP6499758B2 (en) | 2015-07-09 | 2019-04-17 | 富士フイルム株式会社 | Polymerizable composition containing polymerizable compound, film, half mirror for projection image display, and polymerizable compound |
US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
US10882847B2 (en) | 2015-09-28 | 2021-01-05 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
WO2017058768A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
WO2017058915A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
US10730867B2 (en) | 2015-09-28 | 2020-08-04 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
WO2017058807A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
US10858343B2 (en) | 2015-09-28 | 2020-12-08 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
EP3356339A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
JP7015059B2 (en) | 2015-11-16 | 2022-02-15 | アラクセス ファーマ エルエルシー | 2-substituted quinazoline compounds containing substituted heterocyclic groups and their usage |
TWI693275B (en) * | 2016-01-20 | 2020-05-11 | 日商捷恩智股份有限公司 | 4-ring liquid crystal compound having a 2-atom bonding group and 2,3-difluorophenylene, liquid crystal composition, and liquid crystal display element |
TWI744302B (en) * | 2016-05-19 | 2021-11-01 | 日商捷恩智股份有限公司 | Polymerizable composition, liquid crystal composite, optical anisotropic body, liquid crystal display and use thereof |
JP6772549B2 (en) * | 2016-05-23 | 2020-10-21 | Dic株式会社 | Polymerizable compounds and optical anisotropics |
US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
JP6708042B2 (en) * | 2016-07-27 | 2020-06-10 | Jnc株式会社 | Liquid crystalline compound having difluoromethyleneoxy group, liquid crystal composition and liquid crystal display device |
EP3519402A1 (en) | 2016-09-29 | 2019-08-07 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
CN110312711A (en) | 2016-10-07 | 2019-10-08 | 亚瑞克西斯制药公司 | Heterocyclic compound and its application method as RAS inhibitor |
WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
US11059819B2 (en) | 2017-01-26 | 2021-07-13 | Janssen Biotech, Inc. | Fused hetero-hetero bicyclic compounds and methods of use thereof |
WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
EP3573964A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Benzothiophene and benzothiazole compounds and methods of use thereof |
US11274093B2 (en) | 2017-01-26 | 2022-03-15 | Araxes Pharma Llc | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
US11718791B2 (en) | 2017-03-09 | 2023-08-08 | Merck Patent Gmbh | Polymerisable compounds and the use thereof in liquid-crystal displays |
CA3063440A1 (en) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Covalent inhibitors of kras |
WO2018218071A1 (en) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Compounds and methods of use thereof for treatment of cancer |
US11639346B2 (en) | 2017-05-25 | 2023-05-02 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS |
CN108690634A (en) * | 2017-12-08 | 2018-10-23 | 华南师范大学 | A kind of rod shaped liquid crystal and its application |
JP6910527B2 (en) * | 2018-02-14 | 2021-07-28 | 富士フイルム株式会社 | Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate and image display device |
JP6913226B2 (en) * | 2018-02-14 | 2021-08-04 | 富士フイルム株式会社 | Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate and image display device |
CN111349447A (en) * | 2018-12-24 | 2020-06-30 | 河北迈尔斯通电子材料有限公司 | Liquid crystal compound containing difluoromethoxy bridge bond, preparation method and application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4165062B2 (en) * | 2001-12-18 | 2008-10-15 | チッソ株式会社 | Compound having difluoromethyleneoxy and polymer thereof |
JP4088863B2 (en) * | 2002-02-05 | 2008-05-21 | チッソ株式会社 | Fumaric acid diester and its liquid crystalline polymer |
JP4016670B2 (en) * | 2002-02-20 | 2007-12-05 | チッソ株式会社 | Liquid crystalline sorbic acid ester and polymer thereof |
JP4039281B2 (en) * | 2002-03-18 | 2008-01-30 | チッソ株式会社 | Cyclopropane compound and polymer thereof |
-
2003
- 2003-12-22 JP JP2003424376A patent/JP4923380B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005179557A5 (en) | ||
JP6760257B2 (en) | Compounds, liquid crystal compositions and liquid crystal display devices having an alkoxy group or an alkoxyalkyl group and a saturated 6-membered ring. | |
US7704409B2 (en) | Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device | |
JP4048570B2 (en) | Liquid crystal compound having negative dielectric anisotropy value, liquid crystal composition containing the liquid crystal compound, and liquid crystal display device using the liquid crystal composition | |
EP1245660A3 (en) | Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices | |
JP2015180727A5 (en) | ||
JP2011174070A5 (en) | ||
US20110180756A1 (en) | Liquid crystal compound, liquid crystal composition and liquid crystal display device | |
TW201402788A (en) | Polymerizable compound and usage thereof, polymer, liquid crystal composition and liquid crystal display element | |
JP2015206053A5 (en) | ||
JP6136932B2 (en) | Polymerizable compound | |
JPWO2015004947A1 (en) | Polymerizable compound, polymerizable composition, and liquid crystal display device | |
JP6683253B2 (en) | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing the same | |
JP2020011988A5 (en) | ||
JP2007016213A5 (en) | ||
US9073850B2 (en) | Polymerizable compound | |
JP2020011987A5 (en) | ||
JP2007070295A5 (en) | ||
US20160289189A1 (en) | Piperidine derivative, liquid crystal composition, and liquid crystal display element | |
TW201807173A (en) | Low molecular polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | |
JP2002308814A (en) | Compound having difluoroalkoxy at its terminal, liquid crystal composition and liquid crystal display element | |
JP2015030668A5 (en) | ||
JP4654474B2 (en) | Liquid crystalline compound having branched methyl group, liquid crystal composition and liquid crystal display device | |
JP6756365B2 (en) | A low-molecular-weight polar compound that homogenically orients a liquid crystal medium, and a liquid crystal medium containing the same. | |
JP2005281223A5 (en) |